Yeah he'd better. Here is his list of priorities;( WP, DF, and finally us little people). The drug has been approved, conditional or not, it is cleared for consumers to purchase upon availability. Yes, it can be pulled from market should something unforeseeable occur during additional testing (IMO highly unlikely given the severity of patient condition) as well that any other approved drug can be pulled if serious unforeseen issues occur. I hope I'm wrong, but I don't expect to hear anything new apart from recent articles and interviews currently published. I do believe they are communicating with potential suitors and we will be informed in due time. Regarding the pps, we should be valued much higher than where we are now, and hopefully that will remedy itself in the near future as well.
GLTA
